Inventor · disambiguated record
Richard Howard Green
Also filed as: GREEN RICHARD · GREEN RICHARD H · GREEN RICHARD HOWARD
4 granted patents·7 pending applications·80 citations·filing 1996–2009
74Inventor score
Technology areasA61P
Files withEATHERTON ANDREW J3GLAXO GROUP LTD3SMITHKLINE BEECHAM CORP2EATHERTON ANDREW JOHN1GLAXO WELLCOME INC1
Top patents by PatentIndex Score
11 records- 0188US6780869B1Pyrimidine derivativesSMITHKLINE BEECHAM CORP·Filed 2000·Granted Aug 24, 2004·40 cites·19 claims
- 0284US6861441B1Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancerSMITHKLINE BEECHAM CORP·Filed 2000·Granted Mar 1, 2005·39 cites·8 claims
- 0360US7635701B2Pyrimidine derivatives and their use as CB2 modulatorsGLAXO GROUP LTD·Filed 2003·Granted Dec 22, 2009·1 cites·19 claims
- 0454US2010041654A1Pyrimidine Derivatives And Their Use As CB2 ModulatorsEATHERTON ANDREW JOHN·Filed 2009·Application pending·0 cites
- 0545US2005192306A1Pyrimidine derivatives as selective inhibitors of COX-2Filed 2005·Application pending·0 cites
- 0639US2010267755A1Pyrimidine derivativesGLAXO GROUP LTD·Filed 2002·Application pending·0 cites
- 0738US2006247261A1Pyrimidine compoundsEATHERTON ANDREW J·Filed 2003·Application pending·0 cites
- 0836US2007129367A1Pyridine derivatives as cb2 receptor modulatorsEATHERTON ANDREW J·Filed 2003·Application pending·0 cites
- 0936US2006240048A1Pyridine derivatives as cb2 receptor modulatorsEATHERTON ANDREW J·Filed 2003·Application pending·0 cites
- 1034US2008132505A1Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In MedicineGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 1126US6048872AArylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptorsGLAXO WELLCOME INC·Filed 1996·Granted Apr 11, 2000·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Richard Howard Green files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →